ANIK
Anika Therapeutics Inc
Price:  
24.83 
USD
Volume:  
220,823.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Anika WACC - Weighted Average Cost of Capital

The WACC of Anika Therapeutics Inc (ANIK) is 5.7%.

The Cost of Equity of Anika Therapeutics Inc (ANIK) is 7.40%.
The Cost of Debt of Anika Therapeutics Inc (ANIK) is 5.00%.

Range Selected
Cost of equity 6.10% - 8.70% 7.40%
Tax rate 20.30% - 22.40% 21.35%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.1% - 6.3% 5.7%
WACC

Anika WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.42 0.64
Additional risk adjustments 0.0% 0.5%
Cost of equity 6.10% 8.70%
Tax rate 20.30% 22.40%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.1% 6.3%
Selected WACC 5.7%